Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Healthcare Bull 3X Shares

137.05
+2.431.81%
Post-market: 137.900.8500+0.62%19:54 EDT
Volume:67.35K
Turnover:9.26M
Market Cap:185.02M
PE:- -
High:141.50
Open:139.31
Low:135.96
Close:134.62
52wk High:150.00
52wk Low:74.34
Shares:1.35M
Float Shares:1.35M
Volume Ratio:1.27
T/O Rate:4.99%
Dividend:1.27
Dividend Rate:0.92%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Truist Adjusts Price Target on Eli Lilly & Co. to $1,376 From $1,370, Maintains Buy Rating

MT Newswires Live
·
Aug 07

8 ‘trendsetter’ stocks for world’s top mega-trends: Jon Erlichman

Bloomberg
·
Aug 07

Eli Lilly's Incretin Performance Supports Long-Term Growth, Truist Says

MT Newswires Live
·
Aug 07

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)

TIPRANKS
·
Aug 06

Eli Lilly Outperformance and Incretin Momentum Support Buy Rating with Unchanged $1,385 Price Target

TIPRANKS
·
Aug 06

Rumors Swirl That Eli Lilly (LLY) Will Split Its Stock After Blockbuster Earnings

TIPRANKS
·
Aug 06

Eli Lilly is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Aug 06

Scotiabank Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 06

Amazon Pharmacy to Offer GLP-1 Weight-Loss Medications to Medicare Part D Patients

Dow Jones
·
Aug 06

Eli Lilly price target raised to $1,419 from $1,347 at Morgan Stanley

TIPRANKS
·
Aug 06

Wells Fargo Adjusts PT on Eli Lilly and Co. to $1,330 From $1,280, Maintains Overweight Rating

MT Newswires Live
·
Aug 06

Eli Lilly Buy Rating Reaffirmed as Obesity Leadership Drives Outlook; Price Target Raised to $1,344 from $1,334

TIPRANKS
·
Aug 06

Street View: Lilly Remains the Front-Runner as GLP-1 Demand Climbs

Reuters
·
Aug 06

Dow Hits New All-Time High: Investor Sentiment Improves, Fear Index In ‘Greed’ Zone

Benzinga Earnings
·
Aug 06

Eli Lilly (LLY) Stock Climbs On GLP 1 Strength And 86% Margin

Simply Wall St.
·
Aug 06

Eli Lilly : Leerink Partners Raises Target Price to $1,309.00 from $1,232.00

THOMSON REUTERS
·
Aug 06

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy

Dow Jones
·
Aug 06

Eli Lilly Earnings Call Highlights Powerful Growth Momentum

TIPRANKS
·
Aug 06

Global Equities Roundup: Market Talk

Dow Jones
·
Aug 06